Eric Feller
Chief Executive Officer at Targetome NV
Eric Feller active positions
| Companies | Position | Start | End |
|---|---|---|---|
Société de Gestion de Projets et de Valorisation SA
 Société de Gestion de Projets et de Valorisation SA Miscellaneous Commercial ServicesCommercial Services Société de Gestion de Projets et de Valorisation SA operates as a holding company with interests in providing agricultural technology and equipment. It offers scientific technology services in the field of electricity transmission and monitoring of power lines. The company is headquartered in Gembloux, Belgium | Director/Board Member | 2012-05-28 | - |
Targetome NV
 Targetome NV Pharmaceuticals: MajorHealth Technology Targetome SA operates is a biotech company which develops affinity-based targeted therapies against unmet medical needs with initial focus on pancreatic cancer and liver metastases. The firm develops antibody-drug conjugates. The company was founded by Edwin de Pauw and Vincent Castronovo in 2010 and is headquartered in Liege, Belgium. | Director/Board Member | 2016-06-22 | - |
| Chief Executive Officer | 2010-07-04 | - |
Career history of Eric Feller
Statistics
International
| Belgium | 3 |
Operational
| Director/Board Member | 2 |
| Chief Executive Officer | 1 |
Sectoral
| Commercial Services | 2 |
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
Société de Gestion de Projets et de Valorisation SA
Société de Gestion de Projets et de Valorisation SA Miscellaneous Commercial ServicesCommercial Services Société de Gestion de Projets et de Valorisation SA operates as a holding company with interests in providing agricultural technology and equipment. It offers scientific technology services in the field of electricity transmission and monitoring of power lines. The company is headquartered in Gembloux, Belgium | Commercial Services |
Targetome NV
Targetome NV Pharmaceuticals: MajorHealth Technology Targetome SA operates is a biotech company which develops affinity-based targeted therapies against unmet medical needs with initial focus on pancreatic cancer and liver metastases. The firm develops antibody-drug conjugates. The company was founded by Edwin de Pauw and Vincent Castronovo in 2010 and is headquartered in Liege, Belgium. | Health Technology |
- Stock Market
- Insiders
- Eric Feller
- Experience
